Galectin Therapeutics Inc. (GALT)

Galectin Therapeutics Market Cap

Galectin Therapeutics has a market cap or net worth of $228.52 million as of July 24, 2026. Its market cap has increased by 28.02% in one year.

• Market Cap: 228.52M
• Enterprise Value: 353.11M
• 1-Year Change: 28.02%
• Ranking: #3789
• Category: Micro-Cap
• Stock Price: $3.47

Market Cap Chart

Chart

Since September 10, 2003, Galectin Therapeutics's market cap has increased from $106.80M to $228.52M, an increase of 113.97%. That is a compound annual growth rate of 3.38%.

Market Cap History

Date	Market Cap	% Change
Jul 24, 2026	228.50M	-14.80%
Dec 31, 2025	268.20M	231.11%
Dec 31, 2024	81.00M	-21.13%
Dec 29, 2023	102.70M	52.83%
Dec 30, 2022	67.20M	-45.28%
Dec 31, 2021	122.80M	-3.99%
Dec 31, 2020	127.90M	-21.39%
Dec 31, 2019	162.70M	15.31%
Dec 31, 2018	141.10M	18.57%
Dec 29, 2017	119.00M	313.19%
Dec 30, 2016	28.80M	-26.53%
Dec 31, 2015	39.20M	-48.96%
Dec 31, 2014	76.80M	-48.11%
Dec 31, 2013	148.00M	352.60%
Dec 31, 2012	32.70M	-55.81%
Dec 30, 2011	74.00M	32.14%
Dec 31, 2010	56.00M	288.89%
Dec 31, 2009	14.40M	234.88%
Dec 31, 2008	4.30M	-84.81%
Dec 31, 2007	28.30M	111.19%
Dec 29, 2006	13.40M	-83.91%
Dec 30, 2005	83.30M	21.96%
Dec 31, 2004	68.30M	-23.94%
Dec 31, 2003	89.80M	-15.92%
Sep 10, 2003	106.80M	-

View and export this data all the way back to 2003. Sign Up Today.

Data Source: Nasdaq Data Link Last updated: Jul 24, 2026

Market cap data is provided by Nasdaq Data Link. The current market cap updates continuously throughout the trading day, while the historical market cap is updated daily after market close.

Update frequency:

Daily

Last checked:

Jul 26, 2026

Data Sources Report a data error

Related Stocks

Company	Market Cap
Opus Genetics	241.09M
Cartesian Therapeutics	232.70M
Anavex Life Sciences	229.83M
Protara Therapeutics	227.07M
Nautilus Biotechnology	224.93M
Adagene	222.66M
AC Immune	222.21M
Compugen	221.33M